Context Therapeutics (CNTX) Debt Ratio (2020)
Context Therapeutics (CNTX) posted Debt Ratio of 12.62 for Q4 2020.
Context Therapeutics (CNTX) Debt Ratio (2020) Analysis & Trends
Context Therapeutics has reported Debt Ratio for 1 years, with the latest figure at 12.62 in Q4 2020.
- Quarterly Debt Ratio changed N/A year-over-year to 12.62 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was 12.62 (changed N/A YoY) and the FY2020 annual result came in at 12.62, changed N/A from the prior year.
- Debt Ratio held at 12.62 in Q4 2020 per CNTX's latest filing.
- Over five years, Debt Ratio peaked at 12.62 in Q4 2020 and troughed at 12.62 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.05 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.03 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.26 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.47 |
| 10 | Context Therapeutics | 48.18 Mn | 48.18 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 12.62 |